Treatment of chronic heart failure (CHF) remains a major medical problem. Although in the last decades the benefits of several therapies in different patient populations with left ventricular dysfunction have been established, morbidity and mortality of CHF patients are high. Consequently, in the last decade improvement of survival has become the primary therapeutic endpoint in CHF studies, and the evaluation of the influence of (new) drugs on mortality has become crucial. In the present article an overview of the large mortality trials is given, and the shifts and alterations in the drug treatment strategy of CHF are discussed.</p
Chronic heart failure (CHF) is a large medical problem, but in recent years significant progress has...
This article discusses the relevance of the high mortality of cardiovascular diseases (CVD) and thei...
AbstractForty years ago therapy for congestive heart failure was limited largely to the mercurial di...
Treatment of chronic heart failure (CHF) remains a major medical problem. Although in the last decad...
Treatment of chronic heart failure (CHF) remains a major medical problem. Although in the last decad...
This editorial refers to $Decreasing one-year mortality and hospitalization rates for heart failure ...
Few conditions in medicine have a prognosis as bleak as chronic heart failure but recent development...
Heart failure is a major health problem and its prevalence is growing, primarily as a consequence of...
Background—Therapies for patients with chronic heart failure caused by left ventricular systolic dys...
The authors of the article have analyzed the problem of advanced heart failure (AHF). Despite signif...
Large drug trials have become very important to determine which drugs should be used in the treatmen...
Management of heart failure is one of the most important challenges of modern medicine. Heart failur...
Prognosis remains poor for patients with chronic heartfailure (CHF), despite improvements in the pre...
Background— Therapies for patients with chronic heart failure caused by left ventricular systolic d...
Studies done in the USA [1] and Scotland [2] have shownthat there has been a progressive and dramati...
Chronic heart failure (CHF) is a large medical problem, but in recent years significant progress has...
This article discusses the relevance of the high mortality of cardiovascular diseases (CVD) and thei...
AbstractForty years ago therapy for congestive heart failure was limited largely to the mercurial di...
Treatment of chronic heart failure (CHF) remains a major medical problem. Although in the last decad...
Treatment of chronic heart failure (CHF) remains a major medical problem. Although in the last decad...
This editorial refers to $Decreasing one-year mortality and hospitalization rates for heart failure ...
Few conditions in medicine have a prognosis as bleak as chronic heart failure but recent development...
Heart failure is a major health problem and its prevalence is growing, primarily as a consequence of...
Background—Therapies for patients with chronic heart failure caused by left ventricular systolic dys...
The authors of the article have analyzed the problem of advanced heart failure (AHF). Despite signif...
Large drug trials have become very important to determine which drugs should be used in the treatmen...
Management of heart failure is one of the most important challenges of modern medicine. Heart failur...
Prognosis remains poor for patients with chronic heartfailure (CHF), despite improvements in the pre...
Background— Therapies for patients with chronic heart failure caused by left ventricular systolic d...
Studies done in the USA [1] and Scotland [2] have shownthat there has been a progressive and dramati...
Chronic heart failure (CHF) is a large medical problem, but in recent years significant progress has...
This article discusses the relevance of the high mortality of cardiovascular diseases (CVD) and thei...
AbstractForty years ago therapy for congestive heart failure was limited largely to the mercurial di...